Related references
Note: Only part of the references are listed.Role of the signal peptide in the synthesis and processing of the glucagon-like peptide-1 receptor
Y. Huang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Role of CRF Receptor Signaling in Stress Vulnerability, Anxiety, and Depression
Richard L. Hauger et al.
GLUCOCORTICOIDS AND MOOD CLINICAL MANIFESTATIONS, RISK FACTORS, AND MOLECULAR MECHANISMS (2009)
Structural and Functional Evolution of Vertebrate Neuroendocrine Stress Systems
Robert John Denver
TRENDS IN COMPARATIVE ENDOCRINOLOGY AND NEUROBIOLOGY (2009)
CRH Signaling Molecular Specificity for Drug Targeting in the CNS
Damian Refojo et al.
GLUCOCORTICOIDS AND MOOD CLINICAL MANIFESTATIONS, RISK FACTORS, AND MOLECULAR MECHANISMS (2009)
CRF Receptors as a Potential Target in the Development of Novel Pharmacotherapies for Depression
Glenn R. Valdez
CURRENT PHARMACEUTICAL DESIGN (2009)
Molecular Mechanisms of Corticotropin-Releasing Factor Receptor-Induced Calcium Signaling
Eric Gutknecht et al.
MOLECULAR PHARMACOLOGY (2009)
Subtype-Specific Differences in Corticotropin-Releasing Factor Receptor Complexes Detected by Fluorescence Spectroscopy
Laura Milan-Lobo et al.
MOLECULAR PHARMACOLOGY (2009)
The corticotropin-releasing factor receptor type 2a contains an N-terminal pseudo signal peptide
Claudia Rutz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The signal peptide of the rat corticotropin-releasing receptor 1 promotes receptor expression but is not essential for establishing a functional receptor
M Alken et al.
BIOCHEMICAL JOURNAL (2005)
Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells
D Wietfeld et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Improved prediction of signal peptides: SignalP 3.0
JD Bendtsen et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors
S Wüller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
International union of pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands
RL Hauger et al.
PHARMACOLOGICAL REVIEWS (2003)
Coexpression of delta-opioid receptors with mu receptors in GH(3) cells changes the functional response to mu agonists from inhibitory to excitatory
AC Charles et al.
MOLECULAR PHARMACOLOGY (2003)
The extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease in an agonist-dependent process
E Grantcharova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The signal peptide of the G protein-coupled human endothelin B receptor is necessary for translocation of the N-terminal tail across the endoplasmic reticulum membrane
R Köchl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Chemokine receptor homo- or heterodimerization activates distinct signaling pathways
M Mellado et al.
EMBO JOURNAL (2001)
Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-rich export signal in the coiled-coil domain
A Begitt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Oligomerization of μ- and δ-opioid receptors -: Generation of novel functional properties
SR George et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Chaperone selection during glycoprotein translocation into the endoplasmic reticulum
M Molinari et al.
SCIENCE (2000)
Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2
SC Coste et al.
NATURE GENETICS (2000)
Share Paper
